Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30014306HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30014330HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30010713HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30007991HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30010714HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30007992HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30015925HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30015924HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30012871HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TVIS30012872HIVENSG00000198900.7protein_codingTOP1YesNo7150P11387
TCGA Plot Options
Drug Information
GeneTOP1
DrugBank IDDB04882
Drug NameEdotecarin
Target IDBE0000971
UniProt IDP11387
Regulation Type
PubMed IDs17325867; 15929804
CitationsCarvajal RD, Ilson DH, Noy A: Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome. Leuk Lymphoma. 2007 Jan;48(1):192-4.@@Saif MW, Diasio RB: Edotecarin: a novel topoisomerase I inhibitor. Clin Colorectal Cancer. 2005 May;5(1):27-36.
GroupsInvestigational
Direct ClassificationIndolocarbazoles
SMILESOCC(CO)NN1C(=O)C2=C3C(NC4=C3C=CC(O)=C4)=C3N([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=C(C=CC(O)=C4)C3=C2C1=O
Pathways
PharmGKB
ChEMBLCHEMBL435191